Psoriasis
Not recruitingORKA-001 in Patients with Moderate-to-Severe Plaque Psoriasis
ORKA-001 in Patients with Moderate-to-Severe Plaque Psoriasis
Germany- Participants:18–64 years · 65+ years
- Substances:ORKA-001
- Sponsor:Oruka Therapeutics Inc.
Rare diseases
Investigational molecules
Locations
Back to Germany1 607 clinical trials in Bad Segeberg, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)ORKA-001 in Patients with Moderate-to-Severe Plaque Psoriasis
GermanyRO7795068 for Weight Loss in Adults With Obesity or Overweight Without Type 2 Diabetes
GermanyBaricitinib Compared with Adalimumab and Etanercept in Patients with Rheumatoid Arthritis
GermanyEfficacy and Safety of MET097 Once Weekly in People with Overweight or Obesity and Type 2 Diabetes
GermanyA study to evaluate the efficacy and safety of MET097 in people with obesity or overweight.
GermanyA study to evaluate the safety and effectiveness of galvokimig in adults with moderate to severe atopic dermatitis
GermanyA study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)
GermanyEfficacy and Safety Evaluation of Dazodalibep in Patients with Moderate-to-Severe Systemic Sjögren’s Syndrome: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study
GermanyEvaluation of Dazodalibep Efficacy and Safety in Patients with Moderate-to-Severe Sjögren’s Syndrome: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study
GermanyStudy of Trontinemab Compared to Placebo for Patients with Early Symptomatic Alzheimer's Disease
GermanyA study testing trontinemab compared to placebo in patients with early Alzheimer's disease including mild cognitive impairment and mild dementia
GermanyA study to evaluate the safety of dazodalibep in patients with Sjögren's Syndrome over a long period of time
GermanyThe busiest research cities in the country
What the registry says about research in the country
Research focusing on post-catheter ablation patients with atrial fibrillation, evaluating long-term oral anticoagulation versus antiplatelet therapy for reducing cerebral embolic events.
These trials aim to enhance patient outcomes following cardiac procedures.
Investigation of novel treatment approaches for patients with atrial fibrillation who have undergone coronary stent placement, comparing different antithrombotic therapy regimens.
Research focused on optimizing post-procedural medication strategies.
Studies examining treatment strategies for ST-Elevated Myocardial Infarction, comparing different approaches to dual antiplatelet therapy and evaluating imaging-guided revascularization techniques.
Advanced research into optimal treatment pathways for heart attack patients.
Tell us about your condition – we search every trial in Europe and connect you with the right site.